Coherus Oncology (CHRS) Payables (2013 - 2026)
Coherus Oncology (CHRS) reported Payables of $13.17 million for Q2 2026, down 65.0% from $37.62 million a year earlier but up 14.7% from the prior quarter.
Powered by 
Analysis
Coherus Oncology (CHRS) Payables (2013 - 2026) Analysis & Trends
At the end of FY2025, Coherus Oncology posted Payables of $9.92 million, down 65.2% from FY2024.
- Payables has a five-year compound annual growth rate of -8.2% (FY2020 to FY2025).
- By year, Payables came in at $28.46 million in FY2024 (-19.2%), $35.22 million in FY2023 (+205.6%), $11.53 million in FY2022 (-28.7%) and $16.16 million in FY2021 (+6.3%).
- Five-year quarterly Payables spans a low of $9.92 million in Q4 2025 and a high of $126.69 million in Q3 2021.
- Year over year, Payables has now declined in each of the last three quarters, with an average decline of 36.6% over the last eight quarters.
- The high point for year-over-year Payables in five years was Q3 2021 (growth of 956.6%); the low point was Q3 2022 (a decline of 92.2%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $11.48 million (Q1 2026), $9.92 million (Q4 2025) and $24.89 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Payables (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,122.91 Bn | 1,091.50 Bn | 19.71 Bn | 6.11 Bn |
| 2 | Johnson & Johnson | 615.09 Bn | 533.62 Bn | 17.26 Bn | 20.92 Bn |
| 3 | AbbVie | 504.75 Bn | 477.86 Bn | 12.70 Bn | 33.30 Bn |
| 4 | Merck | 360.18 Bn | 314.55 Bn | 12.21 Bn | 5.96 Bn |
| 5 | Novartis Ag | 292.05 Bn | 256.04 Bn | 11.24 Bn | 4.26 Bn |
| 6 | Astrazeneca | 256.09 Bn | 229.78 Bn | 12.86 Bn | 22.89 Bn |
| 7 | Amgen | 233.63 Bn | 189.02 Bn | 7.24 Bn | 2.87 Bn |
| 8 | Gilead Sciences | 194.49 Bn | 168.69 Bn | 6.22 Bn | 674.00 Mn |
| 9 | Pfizer | 168.35 Bn | 114.99 Bn | 10.94 Bn | 7.03 Bn |
| 10 | Coherus Oncology | 155.59 Mn | -480.55 Mn | 10.07 Mn | 13.17 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 13.17 Mn |
| Mar 31, 2026 | 11.48 Mn |
| Dec 31, 2025 | 9.92 Mn |
| Sep 30, 2025 | 24.89 Mn |
| Jun 30, 2025 | 37.62 Mn |
| Mar 31, 2025 | 40.93 Mn |
| Dec 31, 2024 | 28.46 Mn |
| Sep 30, 2024 | 21.89 Mn |
| Jun 30, 2024 | 76.82 Mn |
| Mar 31, 2024 | 38.29 Mn |
| Dec 31, 2023 | 35.22 Mn |
| Sep 30, 2023 | 37.09 Mn |
| Jun 30, 2023 | 29.28 Mn |
| Mar 31, 2023 | 23.23 Mn |
| Dec 31, 2022 | 11.53 Mn |
| Sep 30, 2022 | 9.92 Mn |
| Jun 30, 2022 | 17.49 Mn |
| Mar 31, 2022 | 21.09 Mn |
| Dec 31, 2021 | 16.16 Mn |
| Sep 30, 2021 | 126.69 Mn |
API Access
Coherus Oncology Payables API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=payables&ticker=CHRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "payables", "ticker": "CHRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=payables&ticker=CHRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();